Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
As of close of business last night, Cognition Therapeutics Inc’s stock clocked out at $1.54, up 2.67% from its previous closing price of $1.5. In other words, the price has increased by $2.67 from its previous closing price. On the day, 1.53 million shares were traded. CGTX stock price reached its highest trading level at $1.57 during the session, while it also had its lowest trading level at $1.44.
Ratios:
To gain a deeper understanding of CGTX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.44 and its Current Ratio is at 6.44. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In the most recent recommendation for the company, B. Riley Securities on December 19, 2024, Upgraded its rating to Buy and sets its target price to $1.50 from $1 previously. On November 03, 2021, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $22.Oppenheimer initiated its Outperform rating on November 03, 2021, with a $22 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jan 31 ’25 when Ricciardi Lisa bought 38,851 shares for $0.77 per share. The transaction valued at 30,001 led to the insider holds 38,851 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CGTX now has a Market Capitalization of 135942352 and an Enterprise Value of 96988360.
Stock Price History:
The Beta on a monthly basis for CGTX is 1.27, which has changed by 1.5081434 over the last 52 weeks, in comparison to a change of 0.14402747 over the same period for the S&P500. Over the past 52 weeks, CGTX has reached a high of $3.83, while it has fallen to a 52-week low of $0.22. The 50-Day Moving Average of the stock is -6.51%, while the 200-Day Moving Average is calculated to be 47.03%.
Shares Statistics:
It appears that CGTX traded 1.41M shares on average per day over the past three months and 930210 shares per day over the past ten days. A total of 88.27M shares are outstanding, with a floating share count of 80.16M. Insiders hold about 9.19% of the company’s shares, while institutions hold 17.42% stake in the company. Shares short for CGTX as of 1764288000 were 6396928 with a Short Ratio of 4.54, compared to 1761868800 on 7408085. Therefore, it implies a Short% of Shares Outstanding of 6396928 and a Short% of Float of 7.8.
Earnings Estimates
Cognition Therapeutics Inc (CGTX) is presently subject to a detailed evaluation by 4.0 analysts, each offering their unique perspectives on its market standing.The consensus estimate for the next quarter is -$0.06, with high estimates of -$0.05 and low estimates of -$0.07.
Analysts are recommending an EPS of between -$0.34 and -$0.51 for the fiscal current year, implying an average EPS of -$0.39. EPS for the following year is -$0.34, with 4.0 analysts recommending between -$0.21 and -$0.46.
